ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 681644 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 681644; 2) Community: the network communities that were significantly associated with the response to NSC 681644; 3) Molecule: the relationships between components within communities and NSC 681644; 4) MDR: the compounds that were significantly associated with the NSC 681644.

NSC Compound Enrichment Correlation
NSC 263434 N,N'-Bis(3-methoxy-9-acridinyl)-1,8-octanediamine 0.0490935610249067 0.17259013
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0490935610249067 0.52018756
NSC 301457 Cycloalkannin 0.0490935610249067 0.22166979
NSC 328410 Camptothecin Derivative 0.0490935610249067 0.70925956
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0490935610249067 0.36223069
NSC 371777 Null 0.0490935610249067 0.12360055
NSC 602617 Benzo[g]quinoxaline-5,10-dione, 5,10-dihydro-2,3-dimethyl- 0.0490935610249067 0.025723774
NSC 603578 Platinum, tetrachloro[dimethylsilylenebis(methanamine)]-, (OC-6-22) 0.0490935610249067 0.59815304
NSC 615291 Bizelesin 0.0490935610249067 0.67231776
NSC 619030 Analog of CC-1065 0.0490935610249067 0.746562
Total:64  Current:61    [First] [Prev] [Next] [Last]